Publicaciones en colaboración con investigadores/as de Assistance Publique -Hopitaux De Paris (8)

2024

  1. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

2023

  1. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  2. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  3. The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research

2020

  1. Distinct mutational pattern of myelodysplastic syndromes with and without 5q– treated with lenalidomide

    British Journal of Haematology

2013

  1. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

    Journal of Thrombosis and Haemostasis, Vol. 11, Núm. 1, pp. 71-80

  2. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    Journal of Thrombosis and Haemostasis, Vol. 11, Núm. 1, pp. 56-70

2006

  1. Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium?

    Cardiovascular Research, Vol. 72, Núm. 1, pp. 175-183